Kidney Disease Drugs Market Report

Global and China Kidney Disease Drugs Industry Market Research Report (2017-2028)

  • POSTDATE：Dec 07, 2022
  • PAGES：157
  • REPORT CODE：GMM1442112
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Kidney Disease Drugs industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Roche

    • Jiangxi Jimin Kexin Jinshuibao Pharmaceutical

    • Amgen

    • Hebei Ruisen Pharmaceutical

    • Datong Liqun Pharmaceutical

    • AstraZeneca

    • AbbVie

    • Pfizer

    • Sanofi

    • zhejiang Shengbokang Pharmaceutical

    • Teva Pharmaceutical Industries

    • Kissei Pharmaceutical

    • Changxing Pharmaceutical

    • GlaxoSmithKline

    • Tianjin Tongrentang Group

    • Keryx Biopharmaceuticals

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Tablets

    • Capsule

    • Other

    Application:

    • Chronic Glomerulonephritis

    • Nephrotic Syndrome

    • Chronic Renal Failure

    • Kidney Stones

    • Renal Cyst (polycystic Kidney)

    • Diabetic Nephropathy

    • Hypertensive Nephropathy

    • Purpura Nephritis

    • Lupus Nephritis

    • Pediatric Kidney Disease

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Kidney Disease Drugs Industry Overview

      • 1.1.1 Kidney Disease Drugs Market Scope and Market Segments

      • 1.1.2 Kidney Disease Drugs Industry Characteristics

      • 1.1.3 Global and China Kidney Disease Drugs Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Kidney Disease Drugs Production Value and Growth Rate (2017-2028)

    • 1.2 Global Kidney Disease Drugs Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Tablets

      • 1.2.2 Capsule

      • 1.2.3 Other

    • 1.3 Global Kidney Disease Drugs Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Chronic Glomerulonephritis

      • 1.3.2 Nephrotic Syndrome

      • 1.3.3 Chronic Renal Failure

      • 1.3.4 Kidney Stones

      • 1.3.5 Renal Cyst (polycystic Kidney)

      • 1.3.6 Diabetic Nephropathy

      • 1.3.7 Hypertensive Nephropathy

      • 1.3.8 Purpura Nephritis

      • 1.3.9 Lupus Nephritis

      • 1.3.10 Pediatric Kidney Disease

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Kidney Disease Drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Kidney Disease Drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Kidney Disease Drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Kidney Disease Drugs Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Kidney Disease Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Kidney Disease Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Kidney Disease Drugs Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Kidney Disease Drugs Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Kidney Disease Drugs Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Kidney Disease Drugs Industry Porter's Five Forces Model Analysis

      • 2.2.3 Kidney Disease Drugs Industry PEST Analysis

    • 2.3 Kidney Disease Drugs Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Kidney Disease Drugs Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Kidney Disease Drugs Industry

    Chapter 3 Global and China Kidney Disease Drugs Market, by Manufacturer

    • 3.1 Global and China Kidney Disease Drugs Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Kidney Disease Drugs Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Kidney Disease Drugs Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Kidney Disease Drugs Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Kidney Disease Drugs Market Top 3 Players

    Chapter 4 Global and China Kidney Disease Drugs Market, by Type (2017-2028)

    • 4.1 Kidney Disease Drugs Market Trend, by Type

    • 4.2 Global Kidney Disease Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Kidney Disease Drugs Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Kidney Disease Drugs Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Kidney Disease Drugs Price Trend, by Type (2017-2028)

    • 4.3 China Kidney Disease Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Kidney Disease Drugs Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Kidney Disease Drugs Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Kidney Disease Drugs Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Kidney Disease Drugs Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Kidney Disease Drugs Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Kidney Disease Drugs Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Kidney Disease Drugs Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Kidney Disease Drugs Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Kidney Disease Drugs Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Kidney Disease Drugs Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Kidney Disease Drugs Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Kidney Disease Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Kidney Disease Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Kidney Disease Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Kidney Disease Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Kidney Disease Drugs Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Kidney Disease Drugs Market Analysis

    • 7.1 North America Kidney Disease Drugs Market, by Type

    • 7.2 North America Kidney Disease Drugs Market, by Application

    • 7.3 North America Kidney Disease Drugs Market Analysis and Forecast, by Country

      • 7.3.1 United States Kidney Disease Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Kidney Disease Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Kidney Disease Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Kidney Disease Drugs Market Analysis

    • 8.1 Europe Kidney Disease Drugs Market, by Type

    • 8.2 Europe Kidney Disease Drugs Market, by Application

    • 8.3 Europe Kidney Disease Drugs Market Analysis and Forecast, by Country

      • 8.3.1 Germany Kidney Disease Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Kidney Disease Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Kidney Disease Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Kidney Disease Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Kidney Disease Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Kidney Disease Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Kidney Disease Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Kidney Disease Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Kidney Disease Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Kidney Disease Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Kidney Disease Drugs Market Analysis

    • 9.1 APAC Kidney Disease Drugs Market, by Type

    • 9.2 APAC Kidney Disease Drugs Market, by Application

    • 9.3 APAC Kidney Disease Drugs Market Analysis and Forecast, by Country

      • 9.3.1 China Kidney Disease Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Kidney Disease Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Kidney Disease Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Kidney Disease Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Kidney Disease Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Kidney Disease Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Kidney Disease Drugs Market Analysis

    • 10.1 Latin America, Middle East and Africa Kidney Disease Drugs Market, by Type

    • 10.2 Latin America, Middle East and Africa Kidney Disease Drugs Market, by Application

    • 10.3 Latin America, Middle East and Africa Kidney Disease Drugs Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Kidney Disease Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Kidney Disease Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Kidney Disease Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Kidney Disease Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Kidney Disease Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Kidney Disease Drugs Company Profiles

      • 11.1 Roche

        • 11.1.1 Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Roche Kidney Disease Drugs Product Profiles, Application and Specification

        • 11.1.3 Roche Kidney Disease Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical

        • 11.2.1 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Product Profiles, Application and Specification

        • 11.2.3 Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Amgen

        • 11.3.1 Amgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Amgen Kidney Disease Drugs Product Profiles, Application and Specification

        • 11.3.3 Amgen Kidney Disease Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Hebei Ruisen Pharmaceutical

        • 11.4.1 Hebei Ruisen Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Hebei Ruisen Pharmaceutical Kidney Disease Drugs Product Profiles, Application and Specification

        • 11.4.3 Hebei Ruisen Pharmaceutical Kidney Disease Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Datong Liqun Pharmaceutical

        • 11.5.1 Datong Liqun Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Datong Liqun Pharmaceutical Kidney Disease Drugs Product Profiles, Application and Specification

        • 11.5.3 Datong Liqun Pharmaceutical Kidney Disease Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 AstraZeneca

        • 11.6.1 AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 AstraZeneca Kidney Disease Drugs Product Profiles, Application and Specification

        • 11.6.3 AstraZeneca Kidney Disease Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 AbbVie

        • 11.7.1 AbbVie Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 AbbVie Kidney Disease Drugs Product Profiles, Application and Specification

        • 11.7.3 AbbVie Kidney Disease Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Pfizer

        • 11.8.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Pfizer Kidney Disease Drugs Product Profiles, Application and Specification

        • 11.8.3 Pfizer Kidney Disease Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Sanofi

        • 11.9.1 Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Sanofi Kidney Disease Drugs Product Profiles, Application and Specification

        • 11.9.3 Sanofi Kidney Disease Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 zhejiang Shengbokang Pharmaceutical

        • 11.10.1 zhejiang Shengbokang Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Product Profiles, Application and Specification

        • 11.10.3 zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 Teva Pharmaceutical Industries

        • 11.11.1 Teva Pharmaceutical Industries Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 Teva Pharmaceutical Industries Kidney Disease Drugs Product Profiles, Application and Specification

        • 11.11.3 Teva Pharmaceutical Industries Kidney Disease Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.12 Kissei Pharmaceutical

        • 11.12.1 Kissei Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.12.2 Kissei Pharmaceutical Kidney Disease Drugs Product Profiles, Application and Specification

        • 11.12.3 Kissei Pharmaceutical Kidney Disease Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.13 Changxing Pharmaceutical

        • 11.13.1 Changxing Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.13.2 Changxing Pharmaceutical Kidney Disease Drugs Product Profiles, Application and Specification

        • 11.13.3 Changxing Pharmaceutical Kidney Disease Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.14 GlaxoSmithKline

        • 11.14.1 GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.14.2 GlaxoSmithKline Kidney Disease Drugs Product Profiles, Application and Specification

        • 11.14.3 GlaxoSmithKline Kidney Disease Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.15 Tianjin Tongrentang Group

        • 11.15.1 Tianjin Tongrentang Group Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.15.2 Tianjin Tongrentang Group Kidney Disease Drugs Product Profiles, Application and Specification

        • 11.15.3 Tianjin Tongrentang Group Kidney Disease Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.16 Keryx Biopharmaceuticals

        • 11.16.1 Keryx Biopharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.16.2 Keryx Biopharmaceuticals Kidney Disease Drugs Product Profiles, Application and Specification

        • 11.16.3 Keryx Biopharmaceuticals Kidney Disease Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Kidney Disease Drugs Industry Investment Prospect and Risk Assessment

    • 12.1 Kidney Disease Drugs Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Kidney Disease Drugs Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Kidney Disease Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure China Kidney Disease Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Global Kidney Disease Drugs Production Value and Growth Rate (2017-2028)

    • Figure China Kidney Disease Drugs Production Value and Growth Rate (2017-2028)

    • Figure Global Kidney Disease Drugs Market Size and Growth Rate of Tablets (2017-2028)

    • Figure Global Kidney Disease Drugs Market Size and Growth Rate of Capsule (2017-2028)

    • Figure Global Kidney Disease Drugs Market Size and Growth Rate of Other (2017-2028)

    • Figure Global Kidney Disease Drugs Market Size and Growth Rate of Chronic Glomerulonephritis (2017-2028)

    • Figure Global Kidney Disease Drugs Market Size and Growth Rate of Nephrotic Syndrome (2017-2028)

    • Figure Global Kidney Disease Drugs Market Size and Growth Rate of Chronic Renal Failure (2017-2028)

    • Figure Global Kidney Disease Drugs Market Size and Growth Rate of Kidney Stones (2017-2028)

    • Figure Global Kidney Disease Drugs Market Size and Growth Rate of Renal Cyst (polycystic Kidney) (2017-2028)

    • Figure Global Kidney Disease Drugs Market Size and Growth Rate of Diabetic Nephropathy (2017-2028)

    • Figure Global Kidney Disease Drugs Market Size and Growth Rate of Hypertensive Nephropathy (2017-2028)

    • Figure Global Kidney Disease Drugs Market Size and Growth Rate of Purpura Nephritis (2017-2028)

    • Figure Global Kidney Disease Drugs Market Size and Growth Rate of Lupus Nephritis (2017-2028)

    • Figure Global Kidney Disease Drugs Market Size and Growth Rate of Pediatric Kidney Disease (2017-2028)

    • Figure North America Kidney Disease Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Kidney Disease Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Kidney Disease Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Kidney Disease Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Kidney Disease Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Kidney Disease Drugs Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Kidney Disease Drugs Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Kidney Disease Drugs Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Kidney Disease Drugs Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Kidney Disease Drugs Market Share, by Manufacturer in 2021

    • Figure Global and China Kidney Disease Drugs Market Share, by Manufacturer in 2022

    • Table Global Kidney Disease Drugs Sales Volume, by Type (2017-2028)

    • Table Global Kidney Disease Drugs Sales Volume Share, by Type (2017-2028)

    • Figure Global Kidney Disease Drugs Sales Volume Share, by Type (2017-2028)

    • Table Global Kidney Disease Drugs Sales Value, by Type (2017-2028)

    • Table Global Kidney Disease Drugs Sales Value Share, by Type (2017-2028)

    • Figure Global Kidney Disease Drugs Price Trend, by Type (2017-2028)

    • Table China Kidney Disease Drugs Sales Volume, by Type (2017-2028)

    • Table China Kidney Disease Drugs Sales Volume Share, by Type (2017-2028)

    • Figure China Kidney Disease Drugs Sales Volume Share, by Type (2017-2028)

    • Table China Kidney Disease Drugs Sales Value, by Type (2017-2028)

    • Table China Kidney Disease Drugs Sales Value Share, by Type (2017-2028)

    • Figure China Kidney Disease Drugs Price Trend, by Type (2017-2028)

    • Table Global Kidney Disease Drugs Sales Volume, by Application (2017-2028)

    • Table Global Kidney Disease Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Global Kidney Disease Drugs Sales Volume Share, by Application (2017-2028)

    • Table Global Kidney Disease Drugs Sales Value, by Application (2017-2028)

    • Table Global Kidney Disease Drugs Sales Value Share, by Application (2017-2028)

    • Figure Global Kidney Disease Drugs Sales Value Share, by Application (2017-2028)

    • Table China Kidney Disease Drugs Sales Volume, by Application (2017-2028)

    • Table China Kidney Disease Drugs Sales Volume Share, by Application (2017-2028)

    • Figure China Kidney Disease Drugs Sales Volume Share, by Application (2017-2028)

    • Table China Kidney Disease Drugs Sales Value, by Application (2017-2028)

    • Table China Kidney Disease Drugs Sales Value Share, by Application (2017-2028)

    • Figure China Kidney Disease Drugs Sales Value Share, by Application (2017-2028)

    • Figure China Kidney Disease Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure North America Kidney Disease Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Kidney Disease Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Kidney Disease Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Kidney Disease Drugs Production, Import, Consumption and Export (2017-2022)

    • Table North America Kidney Disease Drugs Sales Volume, by Type (2017-2028)

    • Table North America Kidney Disease Drugs Sales Volume Share, by Type (2017-2028)

    • Figure North America Kidney Disease Drugs Sales Volume Share, by Type (2017-2028)

    • Table North America Kidney Disease Drugs Sales Volume, by Application (2017-2028)

    • Table North America Kidney Disease Drugs Sales Volume Share, by Application (2017-2028)

    • Figure North America Kidney Disease Drugs Sales Volume Share, by Application (2017-2028)

    • Figure United States Kidney Disease Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure United States Kidney Disease Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Canada Kidney Disease Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Kidney Disease Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Kidney Disease Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Kidney Disease Drugs Sales Value and Growth Rate (2017-2028)

    • Table Europe Kidney Disease Drugs Sales Volume, by Type (2017-2028)

    • Table Europe Kidney Disease Drugs Sales Volume Share, by Type (2017-2028)

    • Figure Europe Kidney Disease Drugs Sales Volume Share, by Type (2017-2028)

    • Table Europe Kidney Disease Drugs Sales Volume, by Application (2017-2028)

    • Table Europe Kidney Disease Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Europe Kidney Disease Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Germany Kidney Disease Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Kidney Disease Drugs Sales Value and Growth Rate (2017-2028)

    • Figure UK Kidney Disease Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure UK Kidney Disease Drugs Sales Value and Growth Rate (2017-2028)

    • Figure France Kidney Disease Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure France Kidney Disease Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Italy Kidney Disease Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Kidney Disease Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Kidney Disease Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Kidney Disease Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Spain Kidney Disease Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Kidney Disease Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Kidney Disease Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Kidney Disease Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Poland Kidney Disease Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Kidney Disease Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Russia Kidney Disease Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Kidney Disease Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Kidney Disease Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Kidney Disease Drugs Sales Value and Growth Rate (2017-2028)

    • Table APAC Kidney Disease Drugs Sales Volume, by Type (2017-2028)

    • Table APAC Kidney Disease Drugs Sales Volume Share, by Type (2017-2028)

    • Figure APAC Kidney Disease Drugs Sales Volume Share, by Type (2017-2028)

    • Table APAC Kidney Disease Drugs Sales Volume, by Application (2017-2028)

    • Table APAC Kidney Disease Drugs Sales Volume Share, by Application (2017-2028)

    • Figure APAC Kidney Disease Drugs Sales Volume Share, by Application (2017-2028)

    • Figure China Kidney Disease Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure China Kidney Disease Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Japan Kidney Disease Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Kidney Disease Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Kidney Disease Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Kidney Disease Drugs Sales Value and Growth Rate (2017-2028)

    • Figure India Kidney Disease Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure India Kidney Disease Drugs Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Kidney Disease Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Kidney Disease Drugs Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Kidney Disease Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Kidney Disease Drugs Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Kidney Disease Drugs Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Kidney Disease Drugs Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Kidney Disease Drugs Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Kidney Disease Drugs Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Kidney Disease Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Kidney Disease Drugs Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Kidney Disease Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Kidney Disease Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Kidney Disease Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Kidney Disease Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Kidney Disease Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Kidney Disease Drugs Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Kidney Disease Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Kidney Disease Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Kidney Disease Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Kidney Disease Drugs Sales Value and Growth Rate (2017-2028)

    • Table Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Roche Product Profiles, Application and Specification

    • Table Roche Kidney Disease Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Product Profiles, Application and Specification

    • Table Jiangxi Jimin Kexin Jinshuibao Pharmaceutical Kidney Disease Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Amgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Amgen Product Profiles, Application and Specification

    • Table Amgen Kidney Disease Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Hebei Ruisen Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Hebei Ruisen Pharmaceutical Product Profiles, Application and Specification

    • Table Hebei Ruisen Pharmaceutical Kidney Disease Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Datong Liqun Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Datong Liqun Pharmaceutical Product Profiles, Application and Specification

    • Table Datong Liqun Pharmaceutical Kidney Disease Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table AstraZeneca Product Profiles, Application and Specification

    • Table AstraZeneca Kidney Disease Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table AbbVie Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table AbbVie Product Profiles, Application and Specification

    • Table AbbVie Kidney Disease Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pfizer Product Profiles, Application and Specification

    • Table Pfizer Kidney Disease Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sanofi Product Profiles, Application and Specification

    • Table Sanofi Kidney Disease Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table zhejiang Shengbokang Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table zhejiang Shengbokang Pharmaceutical Product Profiles, Application and Specification

    • Table zhejiang Shengbokang Pharmaceutical Kidney Disease Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Teva Pharmaceutical Industries Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Teva Pharmaceutical Industries Product Profiles, Application and Specification

    • Table Teva Pharmaceutical Industries Kidney Disease Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Kissei Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Kissei Pharmaceutical Product Profiles, Application and Specification

    • Table Kissei Pharmaceutical Kidney Disease Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Changxing Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Changxing Pharmaceutical Product Profiles, Application and Specification

    • Table Changxing Pharmaceutical Kidney Disease Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GlaxoSmithKline Product Profiles, Application and Specification

    • Table GlaxoSmithKline Kidney Disease Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Tianjin Tongrentang Group Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Tianjin Tongrentang Group Product Profiles, Application and Specification

    • Table Tianjin Tongrentang Group Kidney Disease Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Keryx Biopharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Keryx Biopharmaceuticals Product Profiles, Application and Specification

    • Table Keryx Biopharmaceuticals Kidney Disease Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US